ClinVar Miner

Submissions for variant NM_000141.5(FGFR2):c.1025G>A (p.Cys342Tyr) (rs121918487)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Division of Genomic Diagnostics,The Children's Hospital of Philadelphia RCV000014173 SCV000328393 pathogenic Crouzon syndrome 2016-09-17 criteria provided, single submitter clinical testing
Invitae RCV000547490 SCV000659603 pathogenic FGFR2 related craniosynostosis 2019-10-28 criteria provided, single submitter clinical testing This sequence change replaces cysteine with tyrosine at codon 342 of the FGFR2 protein (p.Cys342Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. This variant is not present in population databases (rs121918487, ExAC no frequency). This variant is one of the most commonly observed variants in individuals affected with syndromic craniosynostosis, including Crouzon or Pfeiffer syndromes (PMID: 7987400, 24127277, 25271085). It has also been shown to segregate with Crouzon syndrome in a family (PMID: 8650126). ClinVar contains an entry for this variant (Variation ID: 13263). Experimental studies have shown that this missense change results in constitutive protein activity in cell culture, and a mouse model with this knock-in variant recapitulates many of the disease phenotypes (PMID: 22558232, 8755573, 20133659, 15316116). Several different missense substitutions at this codon (p.Cys342Arg, p.Cys342Ser, p.Cys342Trp) have been determined to be pathogenic (PMID: 24127277, 25271085). This suggests that the cysteine residue is critical for FGFR2 protein function, and that other missense substitutions at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic.
Fulgent Genetics,Fulgent Genetics RCV000762801 SCV000893151 pathogenic Acrocephalosyndactyly type I; Beare-Stevenson cutis gyrata syndrome; Jackson-Weiss syndrome; Levy-Hollister syndrome; Pfeiffer syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Saethre-Chotzen syndrome; Scaphocephaly, maxillary retrusion, and mental retardation; Neoplasm of stomach; Bent bone dysplasia syndrome 2018-10-31 criteria provided, single submitter clinical testing
CeGaT Praxis fuer Humangenetik Tuebingen RCV001090933 SCV001246716 pathogenic not provided 2017-03-01 criteria provided, single submitter clinical testing
Centre for Mendelian Genomics,University Medical Centre Ljubljana RCV001196204 SCV001366745 likely pathogenic Obstructive sleep apnea syndrome; Limitation of neck motion 2019-05-31 criteria provided, single submitter clinical testing This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM2,PP3. This variant was detected in heterozygous state.
OMIM RCV000014173 SCV000034421 pathogenic Crouzon syndrome 1995-07-01 no assertion criteria provided literature only
OMIM RCV000014174 SCV000034422 pathogenic Pfeiffer syndrome 1995-07-01 no assertion criteria provided literature only
Database of Curated Mutations (DoCM) RCV000014173 SCV000510536 likely pathogenic Crouzon syndrome 2016-05-13 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.